INDP
Indaptus Therapeutics Inc
2.50$
+5.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.7% | 93.8% | 94.0% | 92.2% | 92.6% | 90.2% | 91.7% | 93.8% | 94.1% | 100.0% | 100.0% | 100.0% | |
| 89.7% | 89.5% | 89.0% | 89.9% | 89.6% | 78.9% | 71.9% | 90.0% | 85.2% | 91.4% | 68.7% | 63.0% | |
| 89.7% | 89.5% | 89.0% | 89.9% | 89.6% | 78.9% | 71.9% | 90.0% | 85.2% | 91.4% | 68.7% | 96.4% | |
| 13.8% | 19.1% | 14.5% | 24.1% | 27.1% | 46.2% | 48.3% | 124.5% | 32.7% | 66.1% | 42.8% | 5.1% | |
| 13.3% | 18.6% | 14.0% | 23.7% | 27.1% | 46.2% | 48.3% | 124.5% | 32.7% | 66.1% | 42.8% | 5.1% | |
| 0.6% | 0.7% | 0.9% | 1.3% | 1.3% | 1.1% | 1.1% | 95.6% | 0.1% | – | – | – | |
| 3.5% | 5.4% | 3.7% | 5.1% | 6.7% | 11.9% | 24.2% | 9.0% | 10.3% | 5.8% | 25.6% | 5.1% | |
| 86.2% | 80.9% | 85.5% | 75.9% | 72.9% | 53.8% | 51.7% | -24.5% | 67.3% | 33.9% | 57.2% | 94.9% | |
| -232.7% | -304.3% | -449.6% | -655.5% | -683.4% | -823.6% | -1,200.6% | -1,026.4% | -1,069.8% | -873.1% | -3,843.9% | -714.3% | |
| 1.7% | 2.0% | 2.8% | 3.8% | 4.1% | 5.4% | 9.3% | 8.4% | 14.6% | 23.3% | 502.4% | 968.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.